FEATURED TPES FOR CONSUMER APPLICATIONS CO N SU M ER GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES Appearance Hardness Specific Gravity Food Contact UL 94 Suitable Substrates Injection Extrusion ASTM Shore ASTM (D792) Consumer Electronics Series Versaflex™ CE 3120-40 Natural 42A 0.92 - - PC, ABS, PC/ABS, COPE ✔ - Good compression set—ideal for device cases or electronic grips Versaflex™ CE 3120-65 Natural 66A 1.15 - HB PC, ABS, PC/ABS, COPE ✔ - Chemical and abrasion resistant; 4.69 cradle-to-gate PCF—ideal for device cases or electronic grips Versaflex™ CE 3140-65N Natural 65A 1.00 - - PC, ABS, PC/ABS, COPE ✔ - 5G transparent materials—ideal for device cases or gaskets Versaflex™ CE 3140-90N Natural 90A 1.01 - - PC, ABS, PC/ABS, COPE ✔ - 5G transparent materials—ideal for device cases or gaskets Versaflex™ CE 3620 Black/ Natural 65A 1.00 - HB PC, ABS, PC/ABS, COPE ✔ - Chemical and abrasion resistant, hydrolitically stable—ideal for electronic grips/gaskets or wearables Engineering Resin Overmolds Versaflex™ OM 1060X-1 Natural 60A 0.93 ✔ - PC, ABS, PC/ABS ✔ - Versatile OM resin—ideal for grips/gaskets Versaflex™ OM 9-801N Natural 47A 1.04 ✔ HB PC, ABS, PC/ABS, PPO, POM, COPE, PMMA, HIPS ✔ - Soft touch/rubber feel—ideal for grips/gaskets Versaflex™ OM 9-802CL Clear 40A 0.92 ✔ - PC, ABS, PC/ABS, COPE ✔ - Soft touch/rubber feel—ideal for grips/gaskets Versaflex™ OM 6059-9 Black 58A 1.10 - HB PA 6 and 6,6 ✔ - Superior adhesion—ideal for grips, power tools/equipment Versaflex™ OM 6160-1 Black/ Natural 60A 1.11 ✔ HB PA 6 and 6,6 ✔ Superior adhesion—ideal for grips, power tools/equipment Versaflex™ OM 6240-1 Natural 43A 1.09 - - PA 6 and 6,6 ✔ - Superior adhesion — ideal for grips, power tools/equipment Versaflex™ OM 6258-1 Natural 62A 1.09 - - PA 6 and 6,6 ✔ - Superior adhesion—ideal for grips, power tools/equipment Versaflex™ OM 6258-9 Black 62A 1.09 - HB PA 6 and 6,6 ✔ - Superior adhesion—ideal for grips, power tools/equipment Versaflex™ OM 6275-9 Black 75A 1.10 - - PA 6 and 6,6 ✔ - Superior adhesion—ideal for grips, power tools/equipment Versollan™ OM1255NX Black 59A 1.05 - HB PC, ABS, PC/ABS, PC/PBT, COPE ✔ - Superior adhesion—ideal for power tool grips Versollan™ RU 2205-1 Natural 65A 1.16 - HB PC, ABS, PC/ABS, COPE ✔ ✔ High performance, rubber feel GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES Appearance Hardness Specific Gravity Food Contact UL 94 Suitable Substrates Injection Extrusion ASTM Shore ASTM (D792) Special Series Versaflex™ VDT 4202-40B Black 40A 1.00 - - PP ✔ ✔ Vibration dispersion—ideal for washer/dryer feet or shin guards Versaflex™ G2800-17 Pink 18 OO 0.85 - - - ✔ - Skin-like feel—ideal for adult toys Versaflex™ SP 2820-55N Natural 55A 0.91 ✔ - - ✔ ✔ Superior puncture and tear resistance—ideal for dog toys Versaflex™ XP 2850 Natural 55A 0.88 ✔ - - ✔ ✔ Wet grip—ideal for water sports or grips Versaflex™ GP 2810-40N AM US Translucent 45A 0.87 ✔ - - ✔ - Antimicrobial Versaflex™ CE 3120-65 AM Natural 67A 1.15 - - PC, ABS, PC/ABS, COPE ✔ - Antimicrobial for consumer electronics Versalloy™ XL 9045-1 Natural 44A 0.88 ✔ - - ✔ - Excellent flow for long, thin flow paths— ideal for grips or thin wall parts Versalloy™ XL 9055-1 Natural 53A 0.89 ✔ - PP ✔ - Excellent flow for long, thin flow paths— ideal for grips or thin wall parts Versalloy™ XL 9055X-9 Black 53A 0.89 ✔ HB PP ✔ - Excellent flow for long, thin flow paths— ideal for grips or thin wall parts Versalloy™ XL 9070-1 Natural 70A 0.89 ✔ - PP ✔ - Excellent flow for long, thin flow paths— ideal for grips or thin wall parts Versalloy™ XL 9070X-9 Black 70A 0.89 ✔ HB PP ✔ - Excellent flow for long, thin flow paths; 2.54 cradle-to-gate PCF—ideal for grips or thin wall parts Dynaflex™ G7702-9001-02 Black 37A 1.10 - - PP ✔ ✔ High temperature performance—ideal for seals and gaskets Dynalloy™ DT 7910W White 45A 0.93 ✔ - - ✔ ✔ Low compression—ideal for dairy tubing Versaflex™ CL 2000X Clear 3A 0.87 ✔ - - ✔ ✔ Ultra soft Versaflex™ CL 2003X Clear 33 OO 0.87 ✔ - - ✔ ✔ Gel feel Versaflex™ CL30 Clear 30A 0.89 ✔ - PP ✔ ✔ High clarity, high tackiness Versaflex™ CL40 Clear 43A 0.89 ✔ HB - ✔ ✔ High clarity, high tackiness General Purpose Series Versaflex™ GP 2810 Translucent 20A–60A 0.88 ✔ - - ✔ ✔ Unfilled Versaflex™ GP 2810 Translucent 70A–90A 0.89 ✔ HB - ✔ ✔ Unfilled Dynaflex™ G7920 Natural/Black 20A 1.01 ✔ - PP ✔ ✔ Filled Dynaflex™ G7900 Natural/Black 30A–90A 1.05–1.20 ✔ HB PP ✔ ✔ Filled FEATURED TPES FOR CONSUMER APPLICATIONS CO N SU M ER GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES Appearance Hardness Specific Gravity Compression Set @ 23°C Compression Set @ 100°C Food Contact ISO 10993 USP VI UL 94 Suitable Substrates Injection Extrusion ASTM Shore A ASTM (D792) ASTM % ASTM % Tubing Versaflex™ G2705 N Translucent 60 0.89 20 - ✔ ✔ ✔ ✔ PP ✔ ✔ High resiliance, low compression set, and good puncture sealing–ideal for medical and biopharma tubing Versaflex™ HC BT218 Translucent 67 0.89 19 69 - ✔ ✔ ✔ - - ✔ Weldable and kink resistant—ideal for biopharma tubing Versalfex™ HC BIO BT218 Translucent 70 0.88 18 58 - ✔ ✔ - - - ✔ Weldable and kink resistant; 40% bio-derived content (Gen 1 biomass)—ideal for biopharma tubing Versaflex™ HC MT317 Translucent 68 0.89 17 69 - ✔ ✔ ✔ - - ✔ Flexible and kink resistant, high service temperature —ideal for medical and biopharma tubing Versalloy™ HC 9220-70 Natural 70 0.95 17 51 - ✔ ✔ - PP ✔ ✔ High temperature resistance—ideal for peristaltic pump tubing Syringe Components Versaflex™ HC 2110-35N Natural 35 0.89 19 47 - ✔ ✔ - LDPE, PP ✔ - Good puncture sealing and elevated temperature performance—ideal for septums Versaflex™ HC 2110-57B Black 57 1.01 20 37 - ✔ ✔ - - ✔ - Low coefficient of friction and elevated temperature performance—ideal for plungers and stoppers Engineering Resin Overmolds Versaflex™ OM 1040X-1 Translucent 42 0.92 22 - ✔ ✔ ✔ - PC, ABS, PC/ABS ✔ - Good compression set at room temperature— ideal for seals and grips Versaflex™ OM 3060-1 Clear 59 0.90 33 - ✔ ✔ ✔ HB PC, ABS, PC/ABS, PC/PETG, PC/PBT ✔ - Good compression set at room temperature and UV stability—ideal for seals and grips Versaflex™ OM 8940X-1 Clear 40 0.92 20 - ✔ ✔ - - PK, COPE, PC, ABS, PC/ABS ✔ - Excellent chemical resistance to alcohols and disenfectants—ideal for grips on medical devices Versaflex™ OM 4052 Translucent 56 1.01 27 - ✔ - - - PC, ABS, PC/ABS ✔ - Excellent chemical resistance to skin oils, like sebum, and hand lotion—ideal for consumer healthcare applications Versaflex™ OM 4063 Translucent 64 1.12 30 - ✔ - - PC, ABS, PC/ABS ✔ - Excellent chemical resistance to skin oils, like sebum, and hand lotion—ideal for consumer healthcare applications General Purpose Applications Versaflex™ CL E85 Clear 85 0.90 20 72 ✔ ✔ ✔ - - - ✔ High clarity without plasticizers—ideal for extrusion Versaflex™ HC 3810 Series Translucent 20–90 0.88 16 54 - ✔ - - - ✔ - Formulated without animal derivatives, excellent colorability—ideal for seals and labware Versaflex™ G2705 N Translucent 60 0.89 20 - ✔ ✔ ✔ - PP ✔ ✔ High resiliance, low compression set, and good puncture sealing Versalloy™ HC 9220-70 Natural 70 0.95 17 51 - ✔ - - PP ✔ ✔ High temperature resistance Versalloy™ HC 9210 Series Natural 55 & 70 0.89 20 44 - - ✔ - - ✔ - Formulated without animal derivatives— ideal for injection molding long thin flow paths, smooth surface aesthetics Versaflex™ CL2242 Clear 43 0.89 23 - ✔ ✔ ✔ - - ✔ - High clarity maintained after boiling cleaning processes Versaflex™ CL2250 Clear 50 0.89 20 - ✔ ✔ ✔ - - ✔ - High clarity maintained after boiling cleaning processes FEATURED TPES FOR HEALTHCARE APPLICATIONS H EALTH CAR E GENERAL PROPERTIES REGULATORY BONDING PROCESS FEATURES Appearance Hardness Specific Gravity Weatherability* VOC FOG Odor** UL 94 Suitable Substrates Injection Extrusion ASTM Shore A ASTM (D792) Internal QUV 1000hrs (Delta E) VDA 278 μg/g (ppm) VDA 278 μg/g (ppm) Recycled Content Series reSound™ REC OF 7310-80 Black/ Natural (Gray) 80 0.90 0.35 75 379 3 (VDA 270) - PP ✔ 35% PCR/PIR content (food packaging)— ideal for automotive interior applications reSound™ REC OF 7310-90 Black/ Natural (Gray) 90 0.91 0.11 160 557 3 (VDA 270) - PP ✔ 45% PCR/PIR content (food packaging)— ideal for automotive interior applications General Purpose Series OnFlex™ G7705 B Black 42 1.20 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications OnFlex™ G7705 N Natural 44 1.18 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications OnFlex™ G7720 B Black 57 1.16 0.55 - - - HB PP ✔ ✔ Easy processing for a wide variety of applications OnFlex™ G7720 N Natural 55 1.17 3.72 - - - HB PP ✔ ✔ Easy processing for a wide variety of applications OnFlex™ G7820 N Natural 92 1.14 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications Automotive Fasteners & Interior Components OnFlex™ AF 7210 Series Natural 40–90 1.00 - - - - - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 40 1.00 0.49 113 845 2 (SAE J1351, Dry) - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 50 1.00 0.42 51 762 2 (SAE J1351, Dry) - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 60 1.00 0.21 112 1740 1 (SAE J1351, Dry) - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 70 0.99 0.22 105 1976 3 (SAE J1351, Dry) - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 80 1.00 0.32 74 4459 3 (SAE J1351, Dry) - PP ✔ - Low odor and good UV resistance OnFlex™ AF 7210 Black 90 1.00 - - - - - PP ✔ - Low odor and good UV resistance HVAC & Interior Components OnFlex™ LO 7120-45N Natural 45 1.15 3.21 41 521 2 (SAE J1351, Dry) - PP ✔ - Significant reductions in VOCs and fogging compared to traditional TPE technologies GLS™ TPEs with Antimicrobial Technologies OnFlex™ LO 7120-45B AM Black 45 1.13 0.52 - - - - PP ✔ - Imbedded antimicrobial technology FEATURED TPES FOR TRANSPORTATION APPLICATIONS TRAN SPO RTATIO N * Values were taken on 3mm plaques following 1000hrs of continious exposure to UVA-340 ** Samples were conditioned at 23C at 35% RH for 24 hrs.

Compared to our prior adjusted EPS expectations, raw material deflation as well as improving mix from composites and sustainable solutions positively impacted the quarter and more than offset weaker demand conditions.” 2 “Sequentially, we’ve seen modest improvement in Asia, but demand across other regions remains sluggish, particularly in Europe, as consumers remain cautious with continued inflation and rising interest rates,” Mr. Three Months Ended June 30, 2023 Three Months Ended June 30, 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 22.1 $ 0.24 $ 62.8 $ 0.68 Special items, after tax (Attachment 3) 19.6 0.21 3.2 0.03 Amortization expense, after-tax 16.2 0.18 10.5 0.12 Adjusted net income / EPS $ 57.9 $ 0.63 $ 76.5 $ 0.83 Six Months Ended June 30, 2023 Six Months Ended June 30, 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 42.9 $ 0.47 $ 127.2 $ 1.38 Special items, after tax (Attachment 3) 41.9 0.46 9.6 0.10 Amortization expense, after-tax 31.3 0.34 21.3 0.23 Adjusted net income / EPS $ 116.1 $ 1.27 $ 158.1 $ 1.71 8 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Sales $ 824.4 $ 891.0 $ 1,670.1 $ 1,783.2 Cost of sales 583.7 630.1 1,181.8 1,267.9 Gross margin 240.7 260.9 488.3 515.3 Selling and administrative expense 178.4 160.8 368.9 313.0 Operating income 62.3 100.1 119.4 202.3 Interest expense, net (29.4) (16.2) (58.2) (33.1) Other (expense) income, net (0.2) 1.6 0.5 1.0 Income from continuing operations before income taxes 32.7 85.5 61.7 170.2 Income tax expense (10.4) (22.7) (18.1) (42.7) Net income from continuing operations 22.3 62.8 43.6 127.5 Income (loss) from discontinued operations, net of income taxes — 21.9 (0.9) 41.7 Net income 22.3 84.7 42.7 169.2 Net income attributable to noncontrolling interests (0.2) — (0.7) (0.3) Net income attributable to Avient common shareholders $ 22.1 $ 84.7 $ 42.0 $ 168.9 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.24 $ 0.69 $ 0.47 $ 1.39 Discontinued operations — 0.24 (0.01) 0.46 Total $ 0.24 $ 0.93 $ 0.46 $ 1.85 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.24 $ 0.68 $ 0.47 $ 1.38 Discontinued operations — 0.24 (0.01) 0.45 Total $ 0.24 $ 0.92 $ 0.46 $ 1.83 Cash dividends declared per share of common stock $ 0.2475 $ 0.2375 $ 0.4950 $ 0.4750 Weighted-average shares used to compute earnings per common share: Basic 91.1 91.4 91.1 91.4 Diluted 91.9 92.1 91.9 92.2 9 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Cost of sales: Restructuring costs, including accelerated depreciation $ (1.2) $ (2.6) $ (7.8) $ (7.0) Environmental remediation costs (13.0) (3.0) (14.4) (5.0) Reimbursement of previously incurred environmental costs — 7.6 — 8.2 Impact on cost of sales (14.2) 2.0 (22.2) (3.8) Selling and administrative expense: Restructuring (0.5) (2.9) (11.9) (1.3) Legal and other (6.4) 1.2 (10.6) 1.5 Acquisition related costs (0.7) (2.1) (4.2) (5.0) Impact on selling and administrative expense (7.6) (3.8) (26.7) (4.8) Impact on operating income (21.8) (1.8) (48.9) (8.6) Other income (loss), net 0.1 0.9 (0.1) 1.0 Impact on income from continuing operations before income taxes (21.7) (0.9) (49.0) (7.6) Income tax expense (benefit) on above special items 5.5 0.2 12.4 2.0 Tax adjustments(2) (3.4) (2.5) (5.3) (4.0) Impact of special items on net income from continuing operations $ (19.6) $ (3.2) $ (41.9) $ (9.6) Diluted earnings per common share impact $ (0.21) $ (0.03) $ (0.46) $ (0.10) Weighted average shares used to compute adjusted earnings per share: Diluted 91.9 92.1 91.9 92.2 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) June 30, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 528.7 $ 641.1 Accounts receivable, net 506.4 440.6 Inventories, net 359.0 372.7 Other current assets 116.6 115.3 Total current assets 1,510.7 1,569.7 Property, net 1,007.4 1,049.2 Goodwill 1,705.7 1,671.9 Intangible assets, net 1,614.7 1,597.6 Other non-current assets 213.3 196.6 Total assets $ 6,051.8 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term debt $ 2.2 $ 2.2 Accounts payable 428.7 454.4 Accrued expenses and other current liabilities 345.6 412.8 Total current liabilities 776.5 869.4 Non-current liabilities: Long-term debt 2,179.2 2,176.7 Pension and other post-retirement benefits 67.3 67.2 Deferred income taxes 304.8 342.5 Other non-current liabilities 370.3 276.4 Total non-current liabilities 2,921.6 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,334.7 2,334.5 Noncontrolling interest 19.0 18.3 Total equity 2,353.7 2,352.8 Total liabilities and equity $ 6,051.8 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2023 2022 Operating Activities Net income $ 42.7 $ 169.2 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 96.2 71.1 Accelerated depreciation 1.9 3.2 Share-based compensation expense 6.5 6.3 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (66.6) (133.2) Decrease (increase) in inventories 14.0 (45.9) (Decrease) increase in accounts payable (26.2) 98.5 Accrued expenses and other assets and liabilities, net (93.2) (62.5) Net cash (used) provided by operating activities (24.7) 106.7 Investing activities Capital expenditures (45.9) (34.0) Settlement of foreign exchange derivatives — 75.1 Net proceeds from divestiture 7.3 — Net cash used by investing activities (38.6) 41.1 Financing activities Purchase of common shares for treasury — (36.4) Cash dividends paid (45.0) (43.5) Repayment of long-term debt (1.0) (4.4) Other financing (2.3) (4.1) Net cash used by financing activities (48.3) (88.4) Effect of exchange rate changes on cash (0.8) (15.5) Decrease in cash and cash equivalents (112.4) 43.9 Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of period $ 528.7 $ 645.1 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

2 Bestickning av offentliga tjänstemän 2 Kommersiella mutor 3 Betalningar av smörjpengar (facilitation payments) och kickbacks 3 Att arbeta med ombud, distributörer och andra tredje parter 3 Due diligence och godkännandeprocessen 3 Varningssignaler 4 Krav avseende redovisning och bokföring 4 Rapportering av eventuella överträdelser 4 Avients jourlinje för etikfrågor 5 Skydd mot repressalier 5 Snabbreferens: BEKÄMPANDE AV MUTOR OCH KORRUPTION – VAD DU BÖR GÖRA OCH INTE GÖRA 6 1 Vår globala policy för bekämpande av mutor och korruption Avient förbjuder strängeligen bedrägeri, bestickning och andra korrupta affärsmetoder i all vår affärsverksamhet överallt i världen. Detta förbud gäller oavsett om erbjudandet eller betalningen görs direkt eller via en annan person. 2 Detta inbegriper alla offentliga tjänstemän och/eller anställda i den privata sektorn. Innehållsförteckning 2 För att efterleva lagar om mutbrotts- och korruptionsbekämpning ska ingen medarbetare eller tredje part som agerar på Avients vägnar någonsin erbjuda någon, eller ta emot från någon person, vare sig direkt eller indirekt, någon som helst form av gåva, representation eller annat av värde ifall denna muta är avsedd att: • erhålla eller upprätthålla affärer • påverka affärsbeslut • vinna en orättvis fördel Lagar om mutbrotts- och korruptionsbekämpning är vittomfattande och kan tolkas mycket brett.

2 Suborno de funcionários públicos 2 Suborno comercial 3 Pagamentos de facilitação e propinas 3 Trabalhar com agentes, distribuidores e outros terceiros 3 Due diligence e processo de aprovação 3 Sinais de alerta 4 Exigências de manutenção de registros contábeis 4 Denúncias de possíveis violações 4 Linha direta de ética da Avient 4 Proteção contra retaliação 5 Referência rápida: ABAC - O QUE FAZER E O QUE NÃO FAZER 6 1 Nossa política global antissuborno e anticorrupção A Avient proíbe estritamente fraudes, subornos e outras práticas empresariais corruptas em todas as operações da empresa em qualquer lugar do mundo. Para cumprir as leis ABAC, nenhum funcionário ou terceiro que atue em nome da Avient deve oferecer a qualquer pessoa, ou receber de ninguém, direta ou indiretamente, qualquer forma de presente, entretenimento ou coisa de valor como suborno para: • obter ou manter negócios 2 Isso inclui qualquer funcionário público e/ou funcionário do setor privado Sumário 2 • influenciar decisões comerciais • garantir uma vantagem injusta As leis ABAC são abrangentes e podem ser interpretadas de forma muito ampla.

2 Corruption de représentants officiels publics 2 Corruption commerciale 3 Paiements de facilitation et commissions occultes 3 Travailler avec des agents, distributeurs et autres tiers 3 Diligence raisonnable et processus d’approbation 3 Alertes 4 Exigences en matière de comptabilité et de tenue des registres 4 Signalement des violations potentielles 4 Ligne d’assistance Éthique d’Avient 5 Protection contre les représailles 5 Référence rapide : ABAC, À FAIRE ET À NE PAS FAIRE 6 1 Notre Politique mondiale de lutte contre la corruption et les pots-de-vin Avient interdit strictement la fraude, les pots-de-vin et autres pratiques commerciales corrompues dans toutes ses opérations commerciales et partout dans le monde. Cette interdiction s’applique, que l’offre ou le paiement soit effectué directement ou par l’intermédiaire d’une autre personne. 2 Cela comprend tout représentant officiel public ou employé du secteur privé Table des matières 2 Afin de se conformer aux lois ABAC, nul collaborateur ou tiers agissant pour le compte d’Avient ne doit en aucun cas offrir ou recevoir de quiconque, directement ou indirectement, toute forme de cadeau, divertissement ou toute chose de valeur lorsque le pot-de-vin est destiné à : • obtenir ou conserver un marché ; • influencer des décisions commerciales ; • obtenir un avantage injuste.

The underlying growth in these regions helped offset softer demand in Europe and Southeast Asia." 2 2024 Outlook “Looking ahead to the second quarter, we expect adjusted EPS of $0.71, a 13% increase over the prior year," said Jamie Beggs, Senior Vice President and Chief Financial Officer, Avient Corporation. Three Months Ended March 31, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 49.4 $ 0.54 $ 20.8 $ 0.23 Special items, after-tax (Attachment 3) 5.5 0.06 22.3 0.24 Amortization expense, after-tax 14.9 0.16 15.1 0.16 Adjusted net income / EPS $ 69.8 $ 0.76 $ 58.2 $ 0.63 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2024 2023 Sales $ 829.0 $ 845.7 Cost of sales 550.8 598.1 Gross margin 278.2 247.6 Selling and administrative expense 184.2 190.5 Operating income 94.0 57.1 Interest expense, net (26.6) (28.8) Other (expense) income, net (0.9) 0.7 Income from continuing operations before income taxes 66.5 29.0 Income tax expense (16.8) (7.7) Net income from continuing operations 49.7 21.3 Loss from discontinued operations, net of income taxes — (0.9) Net income 49.7 20.4 Net income attributable to noncontrolling interests (0.3) (0.5) Net income attributable to Avient common shareholders $ 49.4 $ 19.9 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.54 $ 0.23 Discontinued operations — (0.01) Total $ 0.54 $ 0.22 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.54 $ 0.23 Discontinued operations — (0.01) Total $ 0.54 $ 0.22 Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 Weighted-average shares used to compute earnings per common share: Basic 91.2 91.0 Diluted 92.0 91.8 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended March 31, 2024 2023 Cost of sales: Restructuring costs, including accelerated depreciation $ 3.6 $ (6.6) Environmental remediation costs (4.0) (1.4) Impact on cost of sales (0.4) (8.0) Selling and administrative expense: Restructuring and employee separation costs (0.7) (11.3) Legal and other (3.5) (4.4) Acquisition related costs (1.6) (3.4) Impact on selling and administrative expense (5.8) (19.1) Impact on operating income (6.2) (27.1) Other income (loss), net — (0.2) Impact on income from continuing operations before income taxes (6.2) (27.3) Income tax benefit on above special items 1.4 6.9 Tax adjustments(2) (0.7) (1.9) Impact of special items on net income from continuing operations $ (5.5) $ (22.3) Diluted earnings per common share impact $ (0.06) $ (0.24) Weighted average shares used to compute adjusted earnings per share: Diluted 92.0 91.8 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 9 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) March 31, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 444.3 $ 545.8 Accounts receivable, net 475.3 399.9 Inventories, net 354.0 347.0 Other current assets 117.1 114.9 Total current assets 1,390.7 1,407.6 Property, net 1,021.7 1,028.9 Goodwill 1,700.1 1,719.3 Intangible assets, net 1,546.5 1,590.8 Other non-current assets 217.1 221.9 Total assets $ 5,876.1 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 9.6 $ 9.5 Accounts payable 428.3 432.3 Accrued expenses and other current liabilities 294.2 331.8 Total current liabilities 732.1 773.6 Non-current liabilities: Long-term debt 2,069.4 2,070.5 Pension and other post-retirement benefits 66.3 67.2 Deferred income taxes 280.0 281.6 Other non-current liabilities 390.5 437.6 Total non-current liabilities 2,806.2 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,321.3 2,319.2 Noncontrolling interest 16.5 18.8 Total equity 2,337.8 2,338.0 Total liabilities and equity $ 5,876.1 $ 5,968.5 10 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Three Months Ended March 31, 2024 2023 Operating activities Net income $ 49.7 $ 20.4 Adjustments to reconcile net income to net cash used by operating activities: Depreciation and amortization 43.8 48.7 Accelerated depreciation 0.5 1.8 Share-based compensation expense 3.3 3.2 Changes in assets and liabilities: Increase in accounts receivable (81.9) (40.2) (Increase) decrease in inventories (12.3) 3.8 Increase (decrease) in accounts payable 1.7 (9.9) Accrued expenses and other assets and liabilities, net (47.6) (50.0) Net cash used by operating activities (42.8) (22.2) Investing activities Capital expenditures (24.4) (20.3) Net proceeds from divestiture — 7.3 Proceeds from plant closures 2.0 — Other investing activities (2.1) — Net cash used by investing activities (24.5) (13.0) Financing activities Cash dividends paid (23.5) (22.5) Repayment of long-term debt (2.7) (0.8) Other financing activities (1.9) (2.3) Net cash used by financing activities (28.1) (25.6) Effect of exchange rate changes on cash (6.1) 2.4 Decrease in cash and cash equivalents (101.5) (58.4) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 444.3 $ 582.7 11 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

This performance reflects our team's focus to capitalize on growth opportunities across the many end markets we serve, with particular success this quarter in packaging and consumer, our two largest end markets.” 2 Dr. Three Months Ended June 30, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 33.6 $ 0.36 $ 22.1 $ 0.24 Special items, after-tax (Attachment 3) 21.8 0.24 19.6 0.21 Amortization expense, after-tax 14.8 0.16 16.2 0.18 Adjusted net income / EPS $ 70.2 $ 0.76 $ 57.9 $ 0.63 Six Months Ended June 30, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 83.0 $ 0.90 $ 42.9 $ 0.47 Special items, after-tax (Attachment 3) 27.3 0.30 41.9 0.46 Amortization expense, after-tax 29.7 0.32 31.3 0.34 Adjusted net income / EPS $ 140.0 $ 1.52 $ 116.1 $ 1.27 8 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Sales $ 849.7 $ 824.4 $ 1,678.7 $ 1,670.1 Cost of sales 592.1 583.7 1,142.9 1,181.8 Gross margin 257.6 240.7 535.8 488.3 Selling and administrative expense 185.1 178.4 369.3 368.9 Operating income 72.5 62.3 166.5 119.4 Interest expense, net (26.6) (29.4) (53.2) (58.2) Other (expense) income, net (0.9) (0.2) (1.8) 0.5 Income from continuing operations before income taxes 45.0 32.7 111.5 61.7 Income tax expense (11.2) (10.4) (28.0) (18.1) Net income from continuing operations 33.8 22.3 83.5 43.6 Loss from discontinued operations, net of income taxes — — — (0.9) Net income $ 33.8 $ 22.3 $ 83.5 $ 42.7 Net income attributable to noncontrolling interests (0.2) (0.2) (0.5) (0.7) Net income attributable to Avient common shareholders $ 33.6 $ 22.1 $ 83.0 $ 42.0 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.37 $ 0.24 $ 0.91 $ 0.47 Discontinued operations — — — (0.01) Total $ 0.37 $ 0.24 $ 0.91 $ 0.46 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.36 $ 0.24 $ 0.90 $ 0.47 Discontinued operations — — — (0.01) Total $ 0.36 $ 0.24 $ 0.90 $ 0.46 Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 $ 0.5150 $ 0.4950 Weighted-average shares used to compute earnings per common share: Basic 91.3 91.1 91.3 91.1 Diluted 92.2 91.9 92.0 91.9 9 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Cost of sales: Restructuring costs, including accelerated depreciation $ 0.2 $ (1.2) $ 3.8 $ (7.8) Environmental remediation costs (21.8) (13.0) (25.8) (14.4) Impact on cost of sales (21.6) (14.2) (22.0) (22.2) Selling and administrative expense: Restructuring and employee separation costs (2.8) (0.5) (3.5) (11.9) Legal and other (2.3) (6.4) (5.8) (10.6) Acquisition related costs (0.5) (0.7) (2.1) (4.2) Impact on selling and administrative expense (5.6) (7.6) (11.4) (26.7) Impact on operating income (27.2) (21.8) (33.4) (48.9) Interest expense, net - financing costs (1.0) — (1.0) — Other income (loss) 0.1 0.1 0.1 (0.1) Impact on income from continuing operations before income taxes (28.1) (21.7) (34.3) (49.0) Income tax benefit on above special items 7.0 5.5 8.4 12.4 Tax adjustments(2) (0.7) (3.4) (1.4) (5.3) Impact of special items on net income from continuing operations $ (21.8) $ (19.6) $ (27.3) $ (41.9) Diluted earnings per common share impact $ (0.24) $ (0.21) $ (0.30) $ (0.46) Weighted average shares used to compute adjusted earnings per share: Diluted 92.2 91.9 92.0 91.9 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 489.4 $ 545.8 Accounts receivable, net 486.6 399.9 Inventories, net 365.9 347.0 Other current assets 117.2 114.9 Total current assets 1,459.1 1,407.6 Property, net 1,019.9 1,028.9 Goodwill 1,685.1 1,719.3 Intangible assets, net 1,515.7 1,590.8 Other non-current assets 228.0 221.9 Total assets $ 5,907.8 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 657.7 $ 9.5 Accounts payable 435.2 432.3 Accrued expenses and other current liabilities 405.3 331.8 Total current liabilities 1,498.2 773.6 Non-current liabilities: Long-term debt 1,420.8 2,070.5 Pension and other post-retirement benefits 63.3 67.2 Deferred income taxes 276.3 281.6 Other non-current liabilities 315.0 437.6 Total non-current liabilities 2,075.4 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,317.5 2,319.2 Noncontrolling interest 16.7 18.8 Total equity 2,334.2 2,338.0 Total liabilities and equity $ 5,907.8 $ 5,968.5 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2024 2023 Operating Activities Net income $ 83.5 $ 42.7 Adjustments to reconcile net income to net cash provided (used) by operating activities: Depreciation and amortization 88.4 96.2 Accelerated depreciation 0.8 1.9 Share-based compensation expense 9.0 6.5 Changes in assets and liabilities: Increase in accounts receivable (97.0) (66.6) (Increase) decrease in inventories (27.3) 14.0 Increase (decrease) in accounts payable 11.9 (26.2) Taxes paid on gain on sale of business — (103.0) Accrued expenses and other assets and liabilities, net (6.2) 9.8 Net cash provided (used) by operating activities 63.1 (24.7) Investing activities Capital expenditures (55.8) (45.9) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 — Other investing activities (2.1) — Net cash used by investing activities (54.5) (38.6) Financing activities Cash dividends paid (47.0) (45.0) Repayment of long-term debt (4.5) (1.0) Other financing activities (3.3) (2.3) Net cash used by financing activities (54.8) (48.3) Effect of exchange rate changes on cash (10.2) (0.8) Decrease in cash and cash equivalents (56.4) (112.4) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 489.4 $ 528.7 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Um Acordo de venda casada é uma prática que envolve o condicionamento da venda de um produto à concordância do cliente de também comprar um produto “casado” diferente. 2 Índice Política antitruste revisada em 2021 Você sabia? Recusas de negociação: acordo com um concorrente para boicotar ou não negociar com uma terceira empresa. 2. Evite contatos desnecessários com concorrentes. 2.

Declara ilícitos los monopolios y los intentos y conspiraciones para monopolizar (incluso si no tienen éxito). 2. Negativas a negociar: acuerdo con un competidor para boicotear o no negociar con una tercera empresa. 2. Evite el contacto innecesario con la competencia. 2.

Закон Шермана: • запрещает соглашения, которые необоснованно ограничивают торговлю (включая фиксирование цен, ограничение объема производства, распределение покупателей или территорий между конкурентами, коллективные бойкоты и некоторые ограничения распределения и лицензирования); • объявляет незаконными монополии, а также попытки и сговоры с целью монополизации (даже безуспешные). 2. Всякий раз, когда ожидается участие в деятельности, несущей риски в антимонопольной сфере, на территории США или за ее пределами, необходимо заранее консультироваться с юридическим отделом компании Avient. 2 Содержание Пересмотренная антимонопольная политика в 2021 г. Избегайте ненужного взаимодействия с конкурентами. 2.